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South Africa (SA) is one of 22 high-burden tuberculosis (TB) 
countries and has among the highest TB incidence and HIV 
prevalence rates globally.[1] SA women in their child-bearing years 
are at high risk of dual TB and HIV infection, which may pose a 
significant threat to their newborns if one or both diseases remain 
undiagnosed and/or untreated. Studies have demonstrated that active 
screening for TB in antenatal and postnatal care settings is beneficial 
to both mothers and babies.[2] However, several local studies have 
demonstrated missed or delayed diagnosis of TB in pregnant SA 
women, with devastating consequences for them and their babies.[3,4]
Despite antenatal TB screening being recommended by the 
2014 National Tuberculosis Management Guidelines,[5] routine 
implementation of screening in busy antenatal clinics is uncommon. 
Furthermore, no official guidelines exist for TB screening of mothers 
in kangaroo mother care (KMC) units during the postpartum 
period, a period that has been shown to carry an increased risk of TB 
disease. [6] Cases of TB exposure in hospitalised newborns and infants 
have been documented, particularly from KMC units in TB-endemic 
settings.[7-10] The risk of TB transmission in KMC units is of particular 
concern, as mothers and infants spend prolonged periods of time 
in small, often poorly ventilated rooms.[7] TB-exposed infants are at 
high risk of developing TB in the absence of appropriate preventive 
therapy, with up to 50% of infants developing TB, 30% of whom 
will have progressive pulmonary or disseminated disease, following 
exposure and infection.[11] 
Undiagnosed TB in mothers poses a serious risk of transmission, 
not only to their own infants but also to other infants in neonatal 
and paediatric wards, their parents and healthcare workers.[12] There 
is a clear need to improve TB control strategies in TB-endemic 
regions, especially in the antenatal, postnatal, neonatal and paedia-
tric healthcare settings.[13] In this case report we report nosocomial 
TB transmission to a neonate in a KMC unit, describe the outbreak 
investigation that ensued, and present recommendations for the 
prevention of TB transmission in maternity, neonatal and paediatric 
care settings in SA.
Case report
The index case
A 9-week-old male infant, born at 34 weeks’ gestational age with a 
birth weight of 2 040 g, presented to Tygerberg Hospital with a short 
history of fast breathing, poor feeding and lethargy. He was one of a 
set of HIV-unexposed twins who had recently been discharged from 
Karl Bremer Hospital, a district hospital, following a 17-day stay in the 
KMC unit. At the time of re-hospitalisation the index case’s twin was 
asymptomatic. The index infant was admitted for investigation and 
treatment of presumed bacterial sepsis and pneumonia. Intravenous 
antibiotic therapy (ampicillin and cefotaxime) was commenced. He 
was transferred to the paediatric intensive care unit for mechanical 
ventilation after respiratory deterioration. A chest radiograph showed 
diffuse bilateral pulmonary infiltrates (Fig. 1, A) on the first day of 
admission. The infant subsequently deteriorated further, requiring 
high-frequency oscillatory ventilation and nitric oxide therapy. 
A  subsequent chest radiograph 5 days later still showed diffuse 
bilateral infiltration with a right upper lobe collapse (Fig. 1, B). Poor 
response to treatment prompted TB investigations; the diagnosis was 
confirmed on Xpert MTB/RIF testing of a tracheal aspirate (confirming 
rifampicin-susceptible Mycobacterium tuberculosis). Four-drug anti-
TB therapy was commenced with isoniazid, rifampicin, ethambutol 
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and pyrazinamide on day 5 of admission. Owing to further clinical 
deterioration and increasing ventilation requirements, ganciclovir, 
high-dose co-trimoxazole, meropenem and vancomycin were also 
initiated. However, the baby died of multiorgan failure 2 days after 
the diagnosis of TB. On questioning the family, there were no known 
household TB source cases. However, the baby’s mother reported 
having shared a room in the KMC unit with another mother who had 
coughed constantly during her 2-week stay.
The source case
After obtaining a more detailed history from the mother of the 
deceased twin and reviewing the hospital records, the possible 
adult TB source case was identified as a 38-year-old HIV-negative 
postpartum woman. She had delivered a baby girl (31 weeks’ 
gestational age, 1 140 g) at Tygerberg Hospital and was transferred 
to a step-down KMC unit at Karl Bremer Hospital 2 weeks later. At 
the KMC unit, the source case had slept in the bed adjacent to the 
index case, his twin and their mother for the full hospital stay. The 
source case’s continuous, productive coughing had been noticed by 
other KMC unit mothers and allegedly reported to the hospital staff, 
but unfortunately no further action to investigate her symptoms 
had been taken. As part of the contact tracing investigation, the 
source case’s medical and laboratory investigations were reviewed 
and it was discovered that she had recently had sputum samples for 
TB investigation submitted from a community TB clinic. Her two 
specimens were microscopy 3+ smear-positive for acid-fast bacilli and 
Xpert MTB/RIF-positive for rifampicin-susceptible M.  tuberculosis. 
On contacting the community TB clinic, we learnt that the source 
case had been recalled to commence TB therapy. Tragically, her own 
premature infant had been declared dead on arrival at a local clinic 
the week before, after a short history of cough and respiratory distress 
(probably TB disease).
Investigation and contact tracing
Liquid TB culture samples from the index case and the presumed 
source case were retrieved from the National Health Laboratory 
Service at Tygerberg Hospital and Green Point TB laboratories, 
respectively, for comparison. Spoligotyping (a rapid, polymerase chain 
reaction-based method for genotyping strains of the M. tuberculosis 
complex that could be used to compare strains) was performed at the 
Stellenbosch University biomolecular laboratory and confirmed that 
the strains were identical, belonging to Spoligo International Type 
119 (X1-family), confirming nosocomial transmission in the KMC 
unit. To minimise further potential morbidity and mortality among 
patients, a contact tracing investigation of mothers, their infants 
and staff was commenced at the two hospitals where the source 
case and her premature infant had been hospitalised. Potential TB 
contacts were defined as infants, mothers and staff whose admission/
service period on the KMC unit coincided with that of the source 
case (regardless of whether they had shared a room with the source 
case). The risk of TB transmission was assessed as low at the referral 
hospital, as the source case had not been an inpatient there and all 
the infants in the ward to which her baby had been admitted were in 
incubators, but telephonic follow-up was conducted (30/46 infants 
were thriving and asymptomatic, 15/46 could not be traced and 
1 infant had died from other causes).
Thirty-four mother-infant pairs were identified from the district 
hospital KMC unit patient register (in total 36 infants, as there were 
two sets of twins). Contact tracing was conducted using postal 
communication, telephone calls and home visits by the local police 
service. Of the 36 infants, 23 (64%) were recalled and 13 could 
not be traced despite repeated attempts. A standardised screening 
method was followed for the mothers (TB symptom screening plus 
a chest radiograph) and for TB-exposed babies (growth chart weight 
plotting to identify failure to thrive, symptom screening for cough, 
lethargy, poor feeding and a chest radiograph). Any radiographic or 
clinical findings in keeping with possible TB prompted collection 
of two gastric aspirates for Xpert testing and mycobacterial culture. 
Of the 23 infants screened, 10 (43%) required TB investigation 
with gastric aspirates; all 10 were acid-fast bacilli smear- and 
mycobacterial culture-negative. After excluding TB disease, 21/23 
(91%) of the traced infants were commenced on a 6-month course 
of isoniazid preventive therapy (IPT). Only the index case and his 
sibling (2/23, 9%) had been/were commenced on treatment for TB 
disease. The twin of the index case was placed on a three-drug TB 
regimen for 6  months owing to symptoms that included cough, a 
suspicious chest radiograph and failure to thrive. The source case’s 
baby had died prior to TB investigations, bringing the total number 
of TB-exposed infants who had confirmed/presumed TB disease to 
3/36 (8%).
A
B
Fig. 1. Chest radiograph of the index patient on admission to the paediatric 
intensive care unit (A) and 5 days later (B).
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Discussion
This case report from an SA neonatal KMC 
unit demonstrates the vulnerability of neo-
nates to nosocomial TB infection and high-
lights the need for prompt identification 
of TB in pregnant and postpartum women 
in TB-endemic countries. Despite several 
published reports of TB transmission to 
hospitalised neonates, most TB-endemic 
settings have yet to implement standardised 
TB screening that is integrated into existing 
antenatal, intrapartum, postpartum, neonatal 
and paediatric healthcare services. [7-10,14,15] 
TB is also the leading cause of non-obstetric-
related maternal death.[16-18]
There are various reasons for the lack of 
maternal TB screening recommendations 
and implementation in low-resource, TB- 
endemic countries.
Most countries do not screen routinely for 
TB in pregnancy, or report the pregnancy 
status of female TB patients. In 2011, there 
were an estimated 216 500 cases of TB in 
pregnant women, with the highest burden 
in Africa (41% of cases globally).[17] Pregnant 
women are at increased risk of developing TB 
disease,[19] but may present nonspecifically 
and/or have overlap of TB symptoms (fatigue 
and malaise) with normal pregnancy-related 
complaints, making the clinical diagnosis of 
TB in pregnancy difficult.[16,17] As a result, 
pulmonary TB and extrapulmonary TB 
disease is often not appropriately investi-
gated,[16,17,20] with a delay in TB diagnosis 
of 4 - 26 weeks on average.[16,21-23] Increased 
awareness of TB risk and clinical presentation 
in pregnant and postpartum women is 
needed for both healthcare staff and patients, 
especially in countries with a high TB burden.
Additional challenges to the prompt 
diagnosis of TB in pregnant women include 
poor access to high-quality maternity 
services, lack of integrated TB screening 
in maternity services, presentation for 
antenatal care late in pregnancy, and 
TB-related stigma.[24-26] Furthermore, the 
evidence base to inform best practices for 
maternal TB screening is limited. Most 
TB programmes use the World Health 
Organization-recommended TB four-
symptom screen to identify the presence 
of any cough, fever, night sweats or weight 
loss. [27-29] The presence of any symptom 
prompts further investigation with TB 
sputum smear microscopy/Xpert test and 
chest radiography when indicated. However, 
the sensitivity of clinical screening for TB 
in pregnant women can be as low as 28%, 
particularly among HIV-infected women. [30] 
Chest radiography in addition to clinical 
symptom screening may be a more effective 
way to identify TB in pregnancy, particu-
larly in settings with a high TB/HIV 
burden. [12,15,28,29,31]
In many cases, discovery of an episode 
of inadvertent TB exposure in a hospital 
setting occurs only after recognition of the 
disease in an index case (often occurring 
long after the TB exposure event). There 
are several challenges in deciding on 
the approach for the exposure/outbreak 
investigations, including establishing the 
identity, location and TB treatment status of 
the source case/s; the infectivity, exposure 
time and TB drug resistance pattern of 
the source case/s; the number of exposed 
infants, staff and parents; the best method 
to trace and recall affected patients; the 
best method of screening for TB disease; 
and whether to provide IPT. For infants 
with TB disease and no known household 
TB source case, nosocomial TB exposure 
during hospitalisation episodes is a strong 
possibility. A major challenge in our 
management of this TB-exposure incident 
was the tracing of babies from the two KMC 
units, as phone numbers and addresses 
were incorrect in many hospital folders, 
and many patients had relocated to other 
provinces following the birth of their baby. 
Among babies who were successfully traced, 
underwent TB screening and received IPT, 
there were no further readmissions and 
the prophylaxis was well tolerated. Both 
hospitals’ KMC units sensitised staff to 
screen for TB in postpartum women being 
admitted on the neonatal wards, and a TB 
screening protocol was implemented at the 
district hospital (Fig. 2).
TB SCREENING TOOL
Date: Ward: Clinic:
TB is an illness caused by a germ that is breathed into the lungs. When lungs are damaged by TB, a person 
coughs, may have fever, night sweats and weight loss. Anyone can get TB and if diagnosed in time, TB 
can be cured with the correct drug treatment. However, without treatment, a person can die from TB. We 
also know that babies of mothers with TB can become very sick and that the best care for all babies is to 
make sure that their mothers are healthy!
We would like to ask you a few questions about TB. This will help us to see if you or your baby needs 
investigations or treatment for TB; and will help us to provide the best possible care for you and your baby 
whilst admitted to the KMC Unit. Your answers to these questions will be handled with confidentiality and 
we ask that you sign your name on the form to say that you agree that the information given can be used 
for the care of you and your baby.
Please ask the nurse or doctor if you have any further questions about TB.
PLEASE ADD BABY STICKER HERE
Known TB CASE
Please complete for ALL mothers admitted to the KMC unit
Have you had TB in the past?
Have you been checked for TB when you were pregnant with this baby?
YES NO If YES, which year?
YES NO
Are you taking any TB medicine now? YES NO
At which clinic/hospital were you diagnosed with TB?
Since when are you taking TB medicine (month and year)?
Where are your tablets?
What TB medicines are you taking?
Where will you get your tablets if these are finished?
Has your newborn baby been investigated for TB? 
With me Home Other
Tablets Injections
YES NO unsure
Please inform the neonatal doctor for further TB investigations of the baby
TB symptom screening –
Answer 'YES' or 'NO' to the following questions
4. Do you have a fever?
3. Do you sweat a lot at night?
2. Do you weigh less than before your pregnancy?
1.  Do you have a cough for more than 2 weeks?
YES NO
If YES to one or more of the 4 TB questions
SUSPECTED TB 
Please inform the neonatal doctor for further TB investigations of the mother
Date referred: HCW name: Mother’s signature:
If NO to all the 
TB questions
NO TB 
Fig. 2. Example of a maternal tuberculosis screening tool for neonatal wards.
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Inadvertent TB exposure in neonatal/KMC wards in SA is likely to 
occur frequently given our high TB incidence and HIV prevalence 
rates among pregnant women. In order to reduce the risk of TB 
transmission to hospitalised infants, SA should encourage routine 
TB screening in antenatal care settings and implement postpartum 
TB screening in neonatal wards before women are moved to KMC 
units (Table 1).
Conclusions
Hospitalised infants and healthcare staff in TB-endemic settings are 
at high risk of TB exposure in healthcare facilities where maternal TB 
screening is not routinely conducted. Active TB screening and case-
finding programmes for pregnant women are an important way to 
improve maternal/infant health and survival in TB-endemic settings. 
Standardised recommendations for TB/HIV screening of pregnant 
and postpartum women should be developed to ensure prompt 
identification of infectious individuals and prevent TB transmission 
in SA healthcare facilities.
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Table 1. Recommendations to optimise identification of TB in pregnant and postpartum women in countries with a high  
TB burden
• Increase awareness of TB in pregnancy and in postpartum women among patients and healthcare workers
• Integrate TB screening in routine antenatal, intrapartum, postpartum and early infant care
• In settings where mothers are admitted with their infants, e.g. neonatal/paediatric wards, implement a TB screening algorithm (prior to 
admission)
• In infants with TB disease and no known household TB contacts, consider the possibility of nosocomial TB transmission during neonatal 
hospitalisation
TB = tuberculosis.
